
Charles River Laboratories International (CRL) Financial Statements
Price: $149.28
Market Cap: $7.63B
Avg Volume: 1.18M
Market Cap: $7.63B
Avg Volume: 1.18M
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Charles River Laboratories International.
Income Statement
Breakdown | December 28, 2024 | December 30, 2023 | December 31, 2022 | December 25, 2021 | December 26, 2020 | December 28, 2019 | December 29, 2018 | December 30, 2017 | December 31, 2016 | December 26, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B |
Cost of Revenue | $2.72B | $2.63B | $2.51B | $2.21B | $1.85B | $1.66B | $1.43B | $1.16B | $1.03B | $832.21M |
Gross Profit | $1.33B | $1.50B | $1.46B | $1.33B | $1.07B | $958.31M | $840.07M | $702.31M | $646.67M | $531.09M |
Gross Profit Ratio | 32.88% | 36.40% | 36.79% | 37.70% | 36.72% | 36.56% | 37.07% | 37.81% | 38.46% | 38.96% |
Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $751.00M | $747.86M | $665.10M | $619.92M | $528.93M | $517.62M | $443.85M | $373.45M | $367.55M | $300.41M |
Other Expenses | $353.47M | $- | $146.58M | $124.86M | $111.88M | $89.54M | $13.26M | $38.54M | $11.90M | $3.01M |
Operating Expenses | $1.10B | $885.29M | $811.68M | $744.78M | $640.81M | $607.16M | $508.68M | $414.82M | $409.25M | $324.64M |
Cost and Expenses | $3.82B | $3.51B | $3.33B | $2.95B | $2.49B | $2.27B | $1.93B | $1.57B | $1.44B | $1.16B |
Interest Income | $8.57M | $5.20M | $780.00K | $652.00K | $834.00K | $1.52M | $812.00K | $690.00K | $1.31M | $1.04M |
Interest Expense | $126.29M | $136.71M | $59.29M | $73.91M | $86.43M | $60.88M | $63.77M | $29.78M | $27.71M | $15.07M |
Depreciation and Amortization | $361.74M | $314.12M | $303.87M | $265.54M | $234.92M | $198.09M | $161.78M | $131.16M | $126.66M | $24.23M |
EBITDA | $581.14M | $1.03B | $1.04B | $854.29M | $759.15M | $581.73M | $507.23M | $457.89M | $377.29M | $305.38M |
EBITDA Ratio | 14.35% | 24.99% | 24.80% | 23.17% | 26.28% | 21.48% | 18.11% | 19.82% | 17.39% | 16.92% |
Operating Income | $227.35M | $617.26M | $650.98M | $589.86M | $432.73M | $351.15M | $331.38M | $287.50M | $237.42M | $206.45M |
Operating Income Ratio | 5.61% | 14.95% | 16.37% | 16.66% | 14.80% | 13.40% | 14.62% | 15.48% | 14.12% | 15.14% |
Total Other Income Expenses Net | $-134.23M | $-35.98M | $-27.99M | $-109.15M | $14.38M | $-47.07M | $-49.70M | $8.67M | $-14.50M | $-11.02M |
Income Before Tax | $93.11M | $581.28M | $622.99M | $480.71M | $447.11M | $304.08M | $281.68M | $296.95M | $222.92M | $195.43M |
Income Before Tax Ratio | 2.30% | 14.08% | 15.67% | 13.58% | 15.29% | 11.60% | 12.43% | 15.99% | 13.26% | 14.33% |
Income Tax Expense | $67.82M | $100.91M | $130.38M | $81.87M | $81.81M | $50.02M | $54.46M | $171.37M | $66.83M | $43.39M |
Net Income | $22.20M | $474.62M | $486.23M | $390.98M | $364.30M | $252.02M | $226.37M | $123.36M | $154.76M | $149.31M |
Net Income Ratio | 0.55% | 11.49% | 12.23% | 11.04% | 12.46% | 9.61% | 9.99% | 6.64% | 9.20% | 10.95% |
EPS | $0.67 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 |
EPS Diluted | $0.66 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 |
Weighted Average Shares Outstanding | 51.27M | 51.23M | 50.81M | 50.29M | 49.55M | 48.73M | 47.95M | 47.48M | 47.01M | 46.50M |
Weighted Average Shares Outstanding Diluted | 51.63M | 51.45M | 51.30M | 51.42M | 50.61M | 49.69M | 49.02M | 48.56M | 47.96M | 47.63M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 28, 2024 | December 30, 2023 | December 31, 2022 | December 25, 2021 | December 26, 2020 | December 28, 2019 | December 29, 2018 | December 30, 2017 | December 31, 2016 | December 26, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $194.61M | $276.77M | $233.91M | $241.21M | $228.42M | $238.01M | $195.44M | $163.79M | $117.63M | $117.95M |
Short Term Investments | $- | $- | $998.00K | $1.06M | $1.02M | $941.00K | $885.00K | $28.49M | $3.77M | $20.52M |
Cash and Short Term Investments | $194.61M | $276.77M | $233.91M | $241.21M | $228.42M | $238.01M | $195.44M | $163.79M | $117.63M | $117.95M |
Net Receivables | $720.91M | $780.38M | $752.39M | $642.88M | $617.74M | $514.03M | $472.25M | $430.02M | $364.05M | $270.07M |
Inventory | $278.54M | $380.26M | $255.81M | $199.15M | $185.69M | $160.66M | $127.89M | $114.96M | $95.83M | $93.73M |
Other Current Assets | $209.01M | $171.26M | $196.92M | $190.85M | $165.17M | $107.25M | $100.90M | $88.78M | $75.02M | $56.70M |
Total Current Assets | $1.40B | $1.61B | $1.44B | $1.27B | $1.20B | $1.02B | $897.84M | $826.62M | $656.83M | $559.23M |
Property Plant Equipment Net | $2.02B | $2.03B | $1.86B | $1.58B | $1.30B | $1.18B | $932.88M | $781.97M | $755.83M | $677.96M |
Goodwill | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B | $1.54B | $1.25B | $804.91M | $787.52M | $438.83M |
Intangible Assets | $723.40M | $864.05M | $955.27M | $1.06B | $787.60M | $689.41M | $610.89M | $369.76M | $394.45M | $280.80M |
Goodwill and Intangible Assets | $3.57B | $3.96B | $3.81B | $3.77B | $2.60B | $2.23B | $1.86B | $1.17B | $1.18B | $719.63M |
Long Term Investments | $218.35M | $243.81M | $311.60M | $201.35M | $221.80M | $122.98M | $88.59M | $71.10M | $45.33M | $32.73M |
Tax Assets | $42.18M | $40.28M | $41.26M | $40.23M | $37.73M | $44.66M | $23.39M | $22.65M | $28.75M | $40.03M |
Other Non-Current Assets | $278.23M | $309.38M | $148.28M | $151.54M | $130.82M | $89.64M | $55.17M | $52.90M | $43.10M | $38.91M |
Total Non-Current Assets | $6.13B | $6.59B | $6.16B | $5.75B | $4.29B | $3.67B | $2.96B | $2.10B | $2.05B | $1.51B |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B |
Account Payables | $140.34M | $168.94M | $205.91M | $198.13M | $122.47M | $111.50M | $66.25M | $77.84M | $68.48M | $36.67M |
Short Term Debt | $- | $- | $50.20M | $36.06M | $74.89M | $58.90M | $34.60M | $31.00M | $27.31M | $17.03M |
Tax Payables | $- | $38.80M | $39.90M | $26.16M | $24.88M | $26.07M | $24.12M | $43.25M | $25.62M | $12.17M |
Deferred Revenue | $248.32M | $241.82M | $264.26M | $219.70M | $207.94M | $171.81M | $145.14M | $117.57M | $127.73M | $81.34M |
Other Current Liabilities | $605.44M | $605.52M | $531.31M | $553.13M | $409.56M | $341.91M | $288.11M | $193.85M | $180.44M | $164.54M |
Total Current Liabilities | $994.10M | $1.06B | $1.09B | $1.03B | $839.75M | $710.18M | $558.22M | $463.50M | $429.59M | $311.76M |
Long Term Debt | $2.72B | $3.07B | $3.10B | $3.17B | $2.09B | $1.97B | $1.66B | $1.14B | $1.23B | $877.76M |
Deferred Revenue Non-Current | $- | $- | $25.80M | $20.58M | $19.48M | $20.98M | $34.42M | $3.94M | $5.77M | $7.89M |
Deferred Tax Liabilities Non-Current | $106.96M | $191.35M | $215.58M | $239.72M | $217.03M | $167.28M | $143.63M | $89.54M | $55.72M | $48.22M |
Other Non-Current Liabilities | $195.21M | $223.19M | $149.03M | $-30.69M | $185.74M | $161.95M | $118.65M | $166.93M | $137.81M | $65.19M |
Total Non-Current Liabilities | $3.03B | $3.48B | $3.49B | $3.40B | $2.51B | $2.32B | $1.96B | $1.40B | $1.43B | $991.17M |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B | $1.30B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $511.00K | $513.00K | $509.00K | $505.00K | $498.00K | $489.00K | $482.00K | $875.00K | $863.00K | $855.00K |
Retained Earnings | $1.81B | $1.89B | $1.43B | $980.75M | $625.41M | $280.33M | $42.10M | $288.66M | $165.30M | $10.54M |
Accumulated Other Comprehensive Income Loss | $-317.35M | $-196.43M | $-262.06M | $-164.74M | $-138.87M | $-178.02M | $-172.70M | $-144.73M | $-253.76M | $-135.55M |
Other Total Stockholders Equity | $1.97B | $1.91B | $1.80B | $1.72B | $1.63B | $1.53B | $1.45B | $900.28M | $924.37M | $857.22M |
Total Stockholders Equity | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B | $1.63B | $1.32B | $1.05B | $836.77M | $733.07M |
Total Equity | $3.50B | $3.66B | $3.02B | $2.59B | $2.14B | $1.67B | $1.34B | $1.06B | $853.78M | $765.56M |
Total Liabilities and Stockholders Equity | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B |
Minority Interest | $41.13M | $62.12M | $47.21M | $57.17M | $29.07M | $31.89M | $20.97M | $18.94M | $17.02M | $32.50M |
Total Liabilities and Total Equity | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B |
Total Investments | $218.35M | $243.81M | $311.60M | $202.41M | $222.83M | $123.92M | $89.48M | $99.59M | $49.10M | $53.25M |
Total Debt | $2.72B | $3.07B | $3.10B | $2.92B | $2.14B | $2.00B | $1.67B | $1.15B | $1.24B | $863.03M |
Net Debt | $2.53B | $2.79B | $2.86B | $2.68B | $1.91B | $1.77B | $1.47B | $981.31M | $1.12B | $745.08M |
Cash Flow Statement
Breakdown | December 28, 2024 | December 30, 2023 | December 31, 2022 | December 25, 2021 | December 26, 2020 | December 28, 2019 | December 29, 2018 | December 30, 2017 | December 31, 2016 | December 26, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | $25.29M | $480.37M | $492.61M | $398.84M | $365.31M | $254.06M | $227.22M | $125.59M | $156.09M | $152.04M |
Depreciation and Amortization | $361.74M | $314.12M | $303.87M | $265.54M | $234.92M | $198.09M | $161.78M | $131.16M | $126.66M | $94.88M |
Deferred Income Tax | $-67.43M | $-50.90M | $-35.88M | $-24.01M | $-133.00K | $-21.89M | $-9.70M | $28.25M | $1.95M | $2.69M |
Stock Based Compensation | $69.89M | $72.05M | $73.62M | $71.47M | $56.34M | $57.27M | $47.35M | $44.00M | $43.64M | $40.12M |
Change in Working Capital | $-30.33M | $-102.38M | $-152.55M | $42.94M | $-26.27M | $6.18M | $14.81M | $5.94M | $-30.02M | $9.62M |
Accounts Receivables | $21.61M | $-33.43M | $-150.57M | $-26.63M | $-85.63M | $-8.32M | $-21.20M | $-48.28M | $-52.78M | $-16.96M |
Inventory | $16.80M | $-62.30M | $-78.52M | $-25.16M | $-18.38M | $-21.40M | $-13.34M | $-17.84M | $-4.02M | $3.36M |
Accounts Payables | $-14.27M | $-20.43M | $-2.65M | $44.90M | $748.00K | $29.77M | $-12.73M | $34.00K | $22.08M | $1.17M |
Other Working Capital | $-54.47M | $13.78M | $79.19M | $49.83M | $76.98M | $6.13M | $62.08M | $72.03M | $4.71M | $22.04M |
Other Non Cash Items | $375.41M | $-29.36M | $-62.02M | $6.01M | $-83.59M | $-12.78M | $-315.00K | $-18.68M | $6.00K | $-12.99M |
Net Cash Provided by Operating Activities | $734.58M | $683.90M | $619.64M | $760.80M | $546.58M | $480.94M | $441.14M | $316.26M | $298.32M | $286.36M |
Investments in Property Plant and Equipment | $-232.97M | $-318.53M | $-324.73M | $-228.77M | $-166.56M | $-140.51M | $-140.05M | $-82.43M | $-55.29M | $-63.25M |
Acquisitions Net | $-5.48M | $-194.78M | $-120.12M | $-1.17B | $-418.63M | $-515.70M | $-824.87M | $47.45M | $-648.48M | $-247.65M |
Purchases of Investments | $-52.88M | $-54.22M | $-158.27M | $-45.55M | $-26.69M | $-22.34M | $-25.12M | $-46.22M | $-40.25M | $-34.23M |
Sales Maturities of Investments | $41.69M | $6.67M | $4.55M | $6.53M | $11.40M | $942.00K | $35.85M | $9.13M | $53.95M | $27.07M |
Other Investing Activities | $4.55M | $-2.29M | $-9.35M | $264.00K | $-1.06M | $-3.89M | $-805.00K | $-516.00K | $3.69M | $-2.22M |
Net Cash Used for Investing Activities | $-245.09M | $-563.15M | $-607.92M | $-1.44B | $-601.54M | $-681.50M | $-955.00M | $-72.59M | $-686.37M | $-320.29M |
Debt Repayment | $-412.19M | $-75.32M | $19.79M | $669.98M | $30.59M | $233.87M | $554.02M | $-135.58M | $388.03M | $75.18M |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Repurchased | $-119.17M | $-24.16M | $-38.65M | $-40.71M | $-23.98M | $-18.09M | $-13.85M | $-106.91M | $-12.27M | $-117.48M |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $-19.56M | $13.96M | $-23.54M | $43.32M | $40.64M | $16.15M | $17.88M | $34.01M | $14.96M | $46.84M |
Net Cash Used Provided by Financing Activities | $-550.93M | $-85.52M | $-42.40M | $672.60M | $47.25M | $231.94M | $558.06M | $-208.48M | $390.73M | $4.55M |
Effect of Forex Changes on Cash | $-17.47M | $8.04M | $25.58M | $17.73M | $794.00K | $11.36M | $-9.47M | $11.23M | $-3.00M | $-12.70M |
Net Change in Cash | $-78.91M | $43.27M | $-5.10M | $13.20M | $-6.93M | $42.73M | $30.99M | $46.44M | $-321.00K | $-42.08M |
Cash at End of Period | $205.57M | $284.48M | $241.21M | $246.31M | $233.12M | $240.05M | $197.32M | $166.33M | $117.63M | $117.95M |
Cash at Beginning of Period | $284.48M | $241.21M | $246.31M | $233.12M | $240.05M | $197.32M | $166.33M | $119.89M | $117.95M | $160.02M |
Operating Cash Flow | $734.58M | $683.90M | $619.64M | $760.80M | $546.58M | $480.94M | $441.14M | $316.26M | $298.32M | $286.36M |
Capital Expenditure | $-232.97M | $-318.53M | $-324.73M | $-228.77M | $-166.56M | $-140.51M | $-140.05M | $-82.43M | $-55.29M | $-63.25M |
Free Cash Flow | $501.61M | $365.37M | $294.91M | $532.03M | $380.01M | $340.42M | $301.09M | $233.83M | $243.03M | $223.11M |